Regulation · EU
Commission Regulation (EU) 2015/2075 of 18 November 2015 amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for abamectin, desmedipham, dichlorprop-P, haloxyfop-P, oryzalin and phenmedipham in or on certain products (Text with EEA relevance)
- Identifier
- CELEX 32015R2075
- Status
- in_force
- Adopted
- 18 November 2015
- Published
- 18 November 2015
- Language
- en
- Official source
- https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32015R2075
- Source provider
- eurlex
- Retrieved
- 2026-08-27T22:29:09.041Z
Identifier
- CELEX: 32015R2075 · eurlex
Direct relationships
PoliticalRepo: CELEX 32015R2075
- Identifier matchPROJECTS_FROM
Same CELEX 32015R2075 projected from PoliticalRepo EUR-Lex row 32015R2075.
LegalInstrument → PoliticalRecord · Open related record